Notizia - Recent Pharma, Healthcare and Biotech Happenings

recent-pharma-biotech-news-and-updates-for-zimmer-bayer-ovid-merck-janssen-roche

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

Roche receives FDA authorization for the quantitative COVID-19 antibody test Roche has got an authorization from the FDA for a more accurate COVID-19 blood test capable of measuring the levels of specific antibodies, which target the cell-unlocking spike protein of coronavirus. The company anticipates the test can aid in tracking the success of vaccines and recognize people who have recovered from infection and could serve as convalescent plasma donors or help in the development of new therapies. The FDA nods for the Elecsys Anti-SARS-CoV-2 S quantitative antibody test that runs on Roche's cobas e analyzers, follows its September launch in Europe after receiv...

Explore More...

Mylan closing Illinois plant; Insys spends $24M; Roche’s Ocrevus; Greece’s corruption prosecutor quits

Tesaro puts AstraZeneca; XELJANZ® receives; Innovus nabs; Alexion brings

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

Mylan closing Illinois plant; Insys spends $24M; Roche’s Ocrevus; Greece’s corruption prosecutor quits

Tesaro puts AstraZeneca; XELJANZ® receives; Innovus nabs; Alexion brings

Letter for AstraZeneca; Patheon on API plant; Sanofi, Regeneron’s Dupixent; Cerulean Pharma and Daré Bioscience enter into deal; Lilly on price hikes

Novartis’s Entresto; AZ, J&J and Lilly sharply cut death rates; CAR-T drugs worth; FDA warns

GSK consolidates DT and TT vaccine, AZ gears up for FDA filing, Novartis comes up with flex pricing, Concordia reports loss

Pfizer faces patent loss; Allergan over generics probe; Sun Pharma rallies

Business Cocktail

NPPA slams; Japan Joins Trump; PCI Pharma Announces Expansion; Merck opens plant; Mylan and Biocon win

More Views & Analysis

Clinigen and Eisai team up; Sanofi, Lonza enter; Fidia to acquire; J&J completes acquisition

Prosecutors rope Pfizer; Pharma groups to FDA; Regeneron simulates; Otsuka & Lundbeck revive;Philidor execs plead

PMV Raises; Argos Shares Plummet; Cidara Flunks in; Sarepta Sells to Gilead; Novartis and NHS Ayrshire & Arran launch

USFDA warns; Vit B3 prevents glaucoma; Zydus Cadila receives nod; U.S. experts soften on DNA editing

Reckitt Acquired Mead Johnson; LabCorp’s acquisition; Ferring collaborates; J&J Licenses

SEC scrutinizes; Acacia meets endpoint; Axovant’s dementia drug; Novartis expands; Aurobindo responds

AMRI enters alliance; Ferring and Enteris deal; Quotient Clinical Acquires; Renova takes over Rights

FDA approves; Sun Pharma Recalls; Mezzion filed; Sanofi’s antibody to treat

Subscribe to our Updates

Daily

Weekly

Monthly